Genentech Director of Finance Salaries in Wilmington, DE | Comparably
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients. read more
EMPLOYEE
PARTICIPANTS
356
TOTAL
RATINGS
2870

Genentech Director of Finance Salaries in Wilmington, DE

The average Genentech Director of Finance in Wilmington, DE earns an estimated $141,006 annually. Genentech's Director of Finance compensation is $21,010 less than the US average for a Director of Finance.

In Wilmington, DE, The Finance Department at Genentech earns $23,812 more on average than the Operations Department.

Last updated a year ago.

$30k
$74k
$117k
$159k
$350k
$600k
$141,006
Average Compensation
$141,006
avg. base

Director of Finance Salaries at Genentech

In Wilmington, DE, Directors of Finance earn $8,766 more than Controllers.

Accounting Manager
$117k*
Senior Accountant
$93k*
Financial Analyst
$70k*
Accountant
$68k*
* estimated salary

Compensation at Genentech by Department

In Wilmington, DE, The Finance Department averages $23,812 more than the Operations Department, and $13,914 less than the IT Department

IT
$97,566 Avg. total comp.
+$14k
Finance
$83,652 Avg. total comp.
Operations
$59,840 Avg. total comp.
-$24k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Genentech reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Genentech reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Genentech Rate Their Compensation

The majority of Directors of Finance at Genentech believe they're compensated fairly. 82% of Directors of Finance at Genentech say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Genentech

×
Rate your company